Does APREMILAST Cause Maternal exposure timing unspecified? 130 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Maternal exposure timing unspecified have been filed in association with APREMILAST (Otezla). This represents 0.1% of all adverse event reports for APREMILAST.
130
Reports of Maternal exposure timing unspecified with APREMILAST
0.1%
of all APREMILAST reports
127
Deaths
130
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From APREMILAST?
Of the 130 reports, 127 (97.7%) resulted in death, 130 (100.0%) required hospitalization, and 130 (100.0%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREMILAST. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does APREMILAST Cause?
Diarrhoea (23,752)
Nausea (21,352)
Psoriasis (19,255)
Headache (17,024)
Drug ineffective (14,121)
Abdominal discomfort (7,653)
Psoriatic arthropathy (7,035)
Vomiting (5,959)
Rash (5,883)
Pain (5,676)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which APREMILAST Alternatives Have Lower Maternal exposure timing unspecified Risk?
APREMILAST vs APREPITANT
APREMILAST vs APROTININ
APREMILAST vs ARANESP
APREMILAST vs ARAVA
APREMILAST vs AREDIA